IDiyas

For the Inventor, By the Inventor

Berlin, Germany

Sybille Beier

USPTO Granted Patents = 35


Average Co-Inventor Count = 5.1

ph-index = 12

Forward Citations = 412(Granted Patents)


Company Filing History:

goldMedal35 out of 1,384 
 
Schering Aktiengesellschaft
 patents

Years Active: 1983-2005

Loading Chart...
Loading Chart...
35 patents (USPTO):Explore Patents
1. 6894038 - Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases (2005-05-17),
2. 5843933 - 11.beta.-aryl-4-estrenes, process for their production as well as their (1998-12-01),
3. 5795881 - Combined use of an antigestagen and a progesterone synthesis inhibitor (1998-08-18),
4. 5744464 - Antigestagens for the inhibition of uterine synthesis of prostaglandin (1998-04-28),
5. 5728689 - 11.beta.-aryl-4-estrenes, process for their production as well as their (1998-03-17),
6. 5569652 - Dihydrospirorenone as an antiandrogen (1996-10-29),
7. 5529993 - 14.alpha., 17.alpha.-ethano-16.alpha.-hydroxy-estratrienes (1996-06-25),
8. 5446178 - Process for preparing 19,11.beta.-bridged steroids (1995-08-29),
9. 5446036 - 13-alkyl-11beta-phenylgonanes (1995-08-29),
10. 5273971 - 13-alkyl-11.beta.-phenylgonanes (1993-12-28),
11. 5244886 - 11.beta.-phenyl-14.beta.H steroids (1993-09-14),
12. 5232915 - 9.alpha.-hydroxy-19,11.beta.-bridged steroids, their production and (1993-08-03),
13. 5134136 - 14.alpha.,17.alpha.-ethanoestratrienes (1992-07-28),
14. 5132299 - 11.beta.-phenyl-4,9,15-estratrienes, their manufacture and (1992-07-21),
15. 5095129 - 19,11 .beta.-bridged steroids, their manufacture and pharmaceutical (1992-03-10),

Title: Innovations in Medical Treatment: The Patents of Sybille Beier

Introduction

Sybille Beier, based in Berlin, Germany, is a notable inventor with an impressive portfolio of 35 patents. Her work primarily revolves around biogenic compounds, aimed at advancing medical treatments, particularly for autoimmune diseases.

Latest Patents

Among her recent noteworthy patents is the use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases. This invention specifically focuses on the use of esters of estriol, such as estriol 3,17-dipropionate and estriol 3,17-dihexanoate, which are designed to treat conditions like multiple sclerosis (MS). Another significant patent filed by Beier details the development of 11.beta.-aryl-4-estrenes, where she outlines a range of compounds possessing antigestagenic, antiglucocorticoid, antimineralocorticoid, and antiandrogenic properties. This patent not only covers the compounds but also the methods for their production and their potential use in pharmaceutical preparations.

Career Highlights

Sybille Beier has made substantial contributions in her field while working at Schering Aktiengesellschaft. Her innovations and patents have placed her at the forefront of research in pharmacology, particularly concerning hormone-related treatments.

Collaborations

Throughout her career, Beier has collaborated with esteemed colleagues, including Walter Elger and Rudolf Wiechert. These partnerships have played a vital role in the development and refinement of her patented technologies.

Conclusion

Sybille Beier stands out as a prominent figure in the realm of innovations and patents, especially in therapeutic applications for autoimmune diseases. Her extensive patent portfolio and collaborations underscore her significant impact on the medical field, establishing her as a leading inventor in her area of expertise.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…